chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast heartbeat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 021M20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Fast heartbeat). At the time of the report, HEART RATE INCREASED (Fast heartbeat) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: other (High) Patient developed fast heart beat and never had it before. No concomitant medications were reported. No treatment details were reported.
Grand mal seizure, duration ~5 minutes.  Witnessed by patient's son. Fell to floor; full body convulsions. Son yelled for his father/my husband.  Husband (physician) said face pale and lips blue; tongue bitten. Son called 911. Taken to ER. CT scan and EKG returned normal. Blood work returned clinically unremarkable. Prescribed Keppra 750 mg BID. Outpatient visit to the Neurology. Transitioning to lamotrigine; going to schedule EEG (in progress). No additional seizures; tongue almost healed.
bad cramps; This spontaneous case was reported by an other health care professional and describes the occurrence of MUSCLE SPASMS (bad cramps) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (bad cramps). At the time of the report, MUSCLE SPASMS (bad cramps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter No treatment medications provided by the reporter.
No further AE's were reported; when GARD ASIL 9 was administered to a patient some of the vaccine leaked down the patients arm; Exposure via skin contact; it was a user error with administering the vaccine; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's concomitant medications, concurrent conditions, medical history and drug allergies were not reported.   On 23-MAR-2022, the patient was vaccinated with HPV rl1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection, at a dose of 0.5 ml one time, lot # U008316 was found to be valid, expiration date 15-AUG-2023 (route of administration and injection site were not reported) for prophylaxis. While vaccination, due to error with administering the vaccine (product administration error) some of the vaccine leaked down the patient's arm (accidental underdose, exposure via skin contact). No further adverse events (AE's) were reported.
Pregnancy: 15 weeks; anomaly in the placenta not yet clarified but could be accreta; due date September 6th 2021. The day after the shot, on Tuesday 3/23 at 7:30am, about 30 minutes after waking up, I felt nausea for a brief instant and immediately the need to vomit; I then had one episode of throwing up, pretty intense. After that I felt weak and cancelled my fitness class I was going to teach in the afternoon. I spent the rest of the day resting and taking care of myself because I felt exhausted.
Numbness; Weird feeling in his tongue; tingling; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness), TONGUE DISORDER (Weird feeling in his tongue) and PARAESTHESIA (tingling) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 15-Feb-2021, the patient experienced HYPOAESTHESIA (Numbness), TONGUE DISORDER (Weird feeling in his tongue) and PARAESTHESIA (tingling). On 16-Feb-2021, HYPOAESTHESIA (Numbness), TONGUE DISORDER (Weird feeling in his tongue) and PARAESTHESIA (tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Redness and hot around where the vaccine was administered. Then the next day I had a fever, cough, headache, and stuffy nose. I have been taking over the counter medications since the symptoms started.  The fever is gone and so is the headache.
About a week and a half after my second vaccine I broke out with herpes simplex blisters on my lower lip that spread to my chin and upper lip
little bit of congestion; common cold; low-grade fever; Sneezing; Coughing; phlegm and muscus, described post-nasal drip; sore throat; blowing runny nose; started having symptoms described as being either flu-like or like that of the common cold; The patient's left arm hurt a little bit, described as its being sore; tired and fatigued for about three days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore), SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip) and OROPHARYNGEAL PAIN (sore throat) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included IBUPROFEN (ADVIL 12 HOUR) for Arthritis, AMLODIPINE, OMEPRAZOLE, ATORVASTATIN CALCIUM (LIPITOR) and COLECALCIFEROL (VITAMIN D3) for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore) and FATIGUE (tired and fatigued for about three days). On 21-May-2021, the patient experienced SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (blowing runny nose), INFLUENZA LIKE ILLNESS (started having symptoms described as being either flu-like or like that of the common cold) and PYREXIA (low-grade fever). On an unknown date, the patient experienced NASAL CONGESTION (little bit of congestion) and NASOPHARYNGITIS (common cold). The patient was treated with PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED 12 HOUR) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (The patient's left arm hurt a little bit, described as its being sore) and FATIGUE (tired and fatigued for about three days) had resolved and SNEEZING (Sneezing), COUGH (Coughing), PRODUCTIVE COUGH (phlegm and muscus, described post-nasal drip), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (blowing runny nose), INFLUENZA LIKE ILLNESS (started having symptoms described as being either flu-like or like that of the common cold) and PYREXIA (low-grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient said he had :odd vocalizations, an abnormal feeling, and gross motor symptoms of flailing of head and extremities". He says he was alert and oriented the entire time. He said it resolved after a few minutes, and recurred again about 30 minutes later to a lesser extent. He says he remembers the events in entirety and spoke to his parents in between the episodes. He has never had this occur before. He has not had any additional episodes since the day of vaccine administration.
This case was reported by a consumer via interactive digital media and described the occurrence of near death experience in a male patient who received Flu unspecified (Influenza vaccine) for prophylaxis. On an unknown date, the patient received Influenza vaccine at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced near death experience (serious criteria GSK medically significant). Influenza vaccine was discontinued. On an unknown date, the outcome of the near death experience was unknown. It was unknown if the reporter considered the near death experience to be related to Influenza vaccine. Additional details were reported as follows: This case was reported by the patient's wife. The age at vaccination was not reported. The nurse recommended the Flu vaccine to the patient which nearly killed him off. It was reported that, the patient would never receive the Flu vaccine again.
Noticed hives about an hour after getting the shot forming all around my body.  Thought it was normal as the covid rash.  Quickly started feeling ill. Had a small amount of trouble breathing and a fever with swelling  and the hives became larger as my skin was flushed. Googled it and it said that this was a normal reaction and common side effects.  So I did not do anything and fell asleep because I felt badly. The next day I woke up to see the bumps all over my body including my digits and pelvic region. Called and talked to my wife she told me to go to the hospital. I started feeling a bit better though and decided against it and took rest that day. The following day the rash had become raised and tender across my body.
Dizziness, Headache, chest pains, tremors, fatigue, chills, sweating Narrative:  employee reports that after several hours of taking the Moderna COVID vaccine that she began to have symptoms of chest pains, inability to sit up without assistance, fatigue, chills, tremor and headache. Employee denied seeking outside medical attention and took Alprazolam and a muscle relaxant instead
Lookns like hives on my arms; Weak; Fatigued; This case was reported by a consumer via call center representative and described the occurrence of weakness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd July 2020, the patient received Shingrix. On 2nd July 2020, immediately after receiving Shingrix, the patient experienced weakness and fatigue. On 8th July 2020, the patient experienced hives. On an unknown date, the outcome of the weakness, fatigue and hives were unknown.   It was unknown if the reporter considered the weakness, fatigue and hives to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. The patient had been weak and fatigued since getting the shot 7 days ago and on the day of reporting, what looks like hives on my arms.  On 8th July 2020, 6 days after vaccination the patient experienced hives The patient asked could this be a reaction to the shot..
Coughing, watery eyes, runny nose, SOB, face swelling. Tx - EPI Shot/O2/BENADRYL/Breathing Tx/Steroid.
Fever of 104. Chills and shaking throughout the night. Fever went down after a day and a half. Body weakness and headache took three days to go away.
report Diarrhea  4 hours post vaccination. Treatment: none. Outcome: Improving and does not Interfere with ADLs.
Pt was fully vaccinated for COVID, Moderna 3/19./1 and 6/10/21, developed covid which caused asthma exacerbation requiring hospitalization on 12/6/21
Headache, NauseaVomiting, Chills Narrative:  Patient reported Chills, nausea, headache post vaccine self treated with advil 400mg oral. This was dose #2.
No adverse event; Dose administered after 30-day Use By Date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and NO ADVERSE EVENT (No adverse event) in a 71-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 021H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: COVID-19 VACCINE (last dose (bivalent)) on 26-Oct-2022, SHINGRIX, PREVNAR 20 and BOOSTRIX. Past adverse reactions to the above products included No adverse reaction with BOOSTRIX, COVID-19 VACCINE, PREVNAR 20 and SHINGRIX.    On 08-Jun-2023, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 08-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date).    No concomitant medication was reported. It was reported  that the patient received other vaccines in the 4 weeks prior to COVID-19 vaccine. HCP stated she was confused because they have a lot number that was received from another facility and they told them that the expiration for that lot number has been extended to 11JUL2023, but when she confirmed in the tracker the expiration date was 01JUN2023. HCP mentioned they already administered 1 dose to a patient. It was a intact cartons with the vial size 2.5 ml. The vial was initially stored in the refrigerator on 02-MAY-2023. The vial did not undergo any temperature excursions. No treatment medication was provided.
On April 6, one week after second dose of vaccine I experienced severe headache which encompassed forehead, sinuses, base of skull and which started in the morning and became worse through the day and lasted into the night.  I took ibuprofen several times during the day and next day was feeling better.  Since then I have had daily wooziness/fogginess to varying degree, accompanied by headache which comes on late in the day.  I am using ibuprofen to alleviate the symptoms, but which does not reduce the fogginess/wooziness.
10:55 15 month old male status post intramuscular DTaP by, MA. Patient reacted with vomiting andcrying. No seiza activity, no hives/ no respiratory distress noted. Vital Signs obtained. and patient ear temp Elevated from 99.9 to 102.9 Parents declined antipyretic  rectal suppository as following clinic standing orders for fever. Dr informed of patient's vomiting and at bedside for Physician evaluation. Dr advised for child to have nasal/ pharyngeal swab for Influenza test. Parents declined. 11:11 Dr reports he suspected an ear infection as well, and an adverse reaction to DTaP vaccine. Parents were advised by doctor to take child to emergency department for further eval. Patient had stopped vomiting and was only awake and crying at this time. Parents left the clinic with child. At 4:19pm same day, Dr contacted mother of child by phone to follow up. Report in patient's chart read:"Patient's symptoms (fever and vomit) had resolved and parents never took child to Emergency Department to avoid child being exposed to other sick children. "
13 days after Vaccine, 10 small pink red vesicular lesion, they scabbed over, cluster on legs/face and no fever
Itching of both hands, have tried using hydrocortizone cream and benedril, little to no effect.
Evaluated 2 days post injection (8/22/18): Subjective: CC: rt. upper arm pain Received hep B#3 vaccine on 8-20-18. Seemed to be administered higher up in the arm than previous vaccines. Noted burning discomfort rt. upper arm. Since that time, has had paresthesias into hand, as well as some shoulder and upper back pain and towards neck. Pt. is left handed. Injection site without erythema or drainage. Objective: Alert, WDWN, NAD. VS as noted. Afebrile. Nontoxic appearing. Mood/affect: appropriate Cor: well perfused Lungs: easy work of breathing Musculoskeletal: C-spine nontender to palpation. Rt. cervical paraspinal tenderness. Rt. upper trapezius tenderness/supraspinatus tenderness with spasm. Rt. upper arm: no erythema at injection site puncture. Mod. tender rt. upper lateral arm. Rt. shoulder: diffuse tenderness of the superior/lateral shoulder area; decreased ROM all directions. Jobe's empty can test: neg Subscapularis push off test: + Belly press: mild pain. Yergason's: neg Speed's: neg Neuro: DTR's 2+/2+ biceps, 0/0 triceps Motor strength exam intact: Deltoids (C5-axillary) Triceps (C6-C7-radial) Wrist extensors (C6-C7-radial) Finger flexion (C8-median) Finger abduction (T1-ulnar) Sensory exam intact to pinprick: Lateral aspect of upper arms (C5) Tip of thumb (C6) Tip of middle finger (C7) Tip of pinky finger (C8) Radial pulse 2+ symmetric Assessment: Adverse effect of other viral vaccines, initial encounter - T50.B95A Pain in right arm - M79.601 Pain in right shoulder - M25.511 Dorsalgia, unspecified - M54.9 Paresthesia Of Skin - R20.2 probable associated muscle spasm Sx developed after receiving hepatitis B vaccination Differential incl. Parsonnage-Turner syndrome (brachial neuritis) referred to primary workers' comp carrier for follow up care.
21 year old male,  received 1st dose of Pfizer COVID vaccine (Lot # EW0167 expiration 5/3/21 @ 1450) on left deltoid at 1024. Patient sitting at vaccinator table and RN explained risks/benefits of vaccine and received verbal consent from patient to give vaccine. Patient told, RN that he is "scared of needles".  RN offered for patient to be vaccinated in the zero gravity chair and patient declined. No past medical history, no allergies, no hx of fainting or seizures. Patient is taking the medication, doxycycline, for face acne. A few seconds after patient received vaccine, he had loss of consciousness, tensed up with a few jerky movements for about 10 seconds. 2 RNs moved patient down to floor and elevated lower extremities. Patient immediately regained consciousness and A&O x4. Patient was diaphoretic. Ice pack placed on back of neck. At 1024, EMS was called by a Ancillary. EMT took vitals and RN recorded vitals at 1026: BP 120/80, HR 56, Sp02 99%. Patient states he is "feeling much better". Patient placed in zero gravity chair. Patient reports he had breakfast (cereal and water) before arriving. Another set of vitals taken at 1031: BP 120/85, HR 60, Sp02 98%. At 1032, EMS arrived and assessed patient. Vital signs were stable. After EMS used lancet to obtain a blood glucose level, patient started feeling "hot" and dizzy again. Patient diaphoretic. At 1040, Vitals by EMS: BP 91/45 on right arm and HR 53 while in zero gravity chair. At 1042, EMS had patient stand up to assess his vitals: BP 89/43 on right arm and HR 57. At 1045, Vitals by EMS: BP 70/33 on right arm and HR 63, taken while standing up. Patient diaphoretic and feeling a little lightheaded. Patient sat back down in zero gravity chair and ice pack placed on back of neck. At 1047, Vitals by EMS: BP 96/56 on right arm and HR 55, taken while in zero gravity chair. Patient left with EMS at 1054 to Hospital. Patient was with his coworker and boss, who was notified of the situation by EMS.
I discovered two days after giving this patient what I thought was his second Moderna dose, that he had in fact already had 2 other Moderna doses at a different pharmacy chain on 12/29/20 and 1/25/21.  I have left a message with the patient and requested a call back to discuss this issue.  As far as I know, there were no adverse effects and patient had waited for the required 15 minutes and had no adverse effects.
Patient received second dose of shingrix 6/10/20 and reported tingling and numbness and injection site reaction shortly after injection. The tingling and numbness in her left arm has continued since. She went to her provider (Dr. @ medical clinic) and they prescribed a steroid which she plans to pick up.
Information has been received from a physician concerning a 60 year old female who on 05-MAR-1997, 30-OCT-2002, 30-DEC-2002, 27-APR-2004, 12-OCT-2005, 22-MAY-2006 and 17-JUL-2006 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5 ml), intramuscularly.  On 17-AUG-2006 the patient had "a positive response against only 2 out of the 23 valents found in (pneumococcal 23v polysaccharide vaccine)." Unspecified medical attention was sought.  Information received on 07-SEP-2006 contained the following adverse experience. "Spleen removed due to rupture" (May of 1997).  Upon internal review "spleen removed due to rupture in May of 1997" was considered to be an other medical event.  Additional information has been requested. (OMIC)
developed a painful, weeping rash on right upper leg and chest a month after second dose of Pfizer vaccine, saw nurse practitioner at my PCP office, diagnosed shingles, prescribed skin cream and gabapentin, cleared up in about 3 weeks
Patient under the age of 18 received the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under the age of 18 received the vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under the age of 18 received the vaccine). On 05-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under the age of 18 received the vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. No treatment information was provided.   Reporter did not allow further contact
Patient became unresponsive, did not eat, little fluid, slept nearly 24 hours per day, became weak, took to ER, no infections, no COVID, no pneumonia, no flu, no heart problems, no recommended further treatments
Left upper arm red, itchy and raised wheal after injection. Mom took child to clinic for evaluation by MD. States left clinic after 1/2 hour, all s/s disappeared resolved called 03/07/05 no concerns.
c/o right arm swelling and redness 6cmx9cm.  No joint swelling or induration. No fever or s/s rash.
My child received the Rotateq vaccine at both 2 and 4 months. At some point in between those two points she developed blood in her stool. Our (wonderful) pediatrician diagnosed it as cow's milk protein intolerance. I am not sure whether this is vaccine related, but wanted to report that this happened, in case other babies experience the same. I am pro-vaccination, but also suspicious of this vaccine given the timing of it and her symptoms, as well as the fact that it is administered orally and contains bovine cells.
itchiness, and sometimes redness, that shows up in different parts of the body. It is still going on, 8 months later. Dr. prescribed Prednisone 2x20mg/d for 5 days. + Hydroxyzine 14 daysx1 25mg
Incidental COVID positive No URI or new respiratory symptoms.  Likely asymptomatic, patient fully vaccinated.  No COVID therapies at this time but appropriate isolation.